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Introduction
Th e way we die has changed signiﬁ cantly during the past 
half-century. Once a sudden and unexpected event, death 
has become an actively managed and often prolonged 
process that occurs more often in hospitals than in the 
community [1,2]. Advances in biotechnology, biomedi-
cine and critical care, in particular, have transformed the 
way we die [3-5]. Organ failure, for example, is no longer 
inextricably linked to death. Patients with end-stage renal 
disease are routinely dialyzed for many years. Th e lives of 
patients with cardiac failure can be prolonged with 
inotropic and chronotropic therapies, and patients with 
respiratory failure can receive invasive and non-invasive 
ventilation in hospital or at home. Also, for more than 
100,000 patients per year of the estimated 1.7  million 
patients worldwide in need of transplant for failing 
organs [6,7], the transplantation of organs and tissues 
from patients that have died in intensive care settings 
provide signiﬁ cant beneﬁ ts  – reducing mortality and 
morbidity, increasing long-term survival, increasing 
quality of life and reducing the economic burden of the 
cost of healthcare for patients with chronic diseases [8].
Th e ICU has therefore come to play multiple important 
roles in contemporary healthcare  – providing access to 
advanced life support, supporting organ donation and 
tissue transplantation programs, and providing end-of-
life care for those in whom any further treatment is futile 
[9]. While these functions are generally managed without 
diﬃ  culty, they may, at times, create an unavoidable 
tension, particularly when intensivists must mediate 
between professional and social obligations to provide 
patients with a good death [10,11], to eﬀ ectively use 
scarce health resources and to support organ trans-
plantation through the identiﬁ cation and management of 
people who are, or may become, brain dead.
Brain death is the most important method for pro-
curing deceased organs for transplantation, both because 
of the number of potential organ donors that it makes 
available and also because of the unparalleled viability of 
the organs retrieved [12]. But this method, in itself, 
creates a unique challenge because, where brain death is 
anticipated, the interests of the patient, and the public 
beneﬁ t that accrues from the organs potentially removed 
from that patient may diverge, creating tension regarding 
the most appropriate approach to the management of the 
patient’s death. Th e successful management of this 
tension may be the major determinant of the degree to 
which a country is able to meet its organ donation 
requirements. Th e ICU has therefore become the place in 
which both medicine and society confront a choice 
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between increasing organ donation and the provision of a 
less invasive approach to end-of-life care, where we, 
collectively, balance the intimacy of a good death and the 
utility of increased donation rates, through provision of 
intensive care until brain death occurs.
Relationship between organ donation and brain 
death
Recent multi-year analyses of deceased donor data from 
both the Council of Europe and the International Regis try 
of Donation and Transplants have shown that there is a 
clear division in deceased organ donation performance 
between those countries that have the highest donation 
rates and those with lower deceased donation perfor-
mance [13-15]. Th is division occurs at approximately 20 
deceased donors per million population per year. Th ere 
are nine countries that consistently achieve donation 
rates above this level despite having dramatically reduced 
death rates from the types of rates of trauma that are 
most commonly associated with organ donation [13]: 
Spain, Portugal, Puerto Rico, Croatia, the USA, France, 
Austria, Belgium and Italy (Figure  1). Crucially, each of 
these countries’ high donor rates is due to the high rates 
of donation after brain death (DBD) and not due to the 
high rates of donation after cardiocirculatory death 
(DCD) [16-22] (Figure 2).
While DCD plays an increasingly central role in the 
organ donor policies in many countries and has 
contributed to raising organ donation rates in Spain, 
France, Belgium, the USA, the UK and Australia, DCD 
strategies are not unproblematic. Although DCD organ 
recovery and graft survival rates for kidneys and lungs now 
approach those of DBD donors in many countries [23,24], 
recovery rates for other DCD organs – especially livers – 
remain less than those following DBD [25]. Recovery rates 
following DCD are also approximately 1.5 times lower, per 
donor, than DBD and there are some data to suggest that 
increased DCD donation may come at the expense of 
reducing DBD donation [26,27]. An international 
comparison of deceased donation rates demonstrates 
clearly that the high DBD rates observed in the leading 
donor countries are directly associated with high rates of 
brain death (>40 per million population) [28] (Figure 3).
Th ere are many factors that determine whether a 
person becomes an organ donor and, consequently, many 
reasons why the deceased organ donor pool may be 
diminished. Reductions in the rates of traumatic brain 
injury – speciﬁ cally, traﬃ  c and stroke fatalities together 
with advances in emergency and critical care  – have 
reduced the numbers of patients reaching brain death 
criteria and therefore reduced the number of potential 
organ donors [13,29-31]. Also, while not directly aﬀ ecting 
the rates of brain death, the aging of the population and 
increases in the rates of noncommunicable diseases (that 
is, diabetes) may serve to reduce the number of organs 
suitable for transplant. While both upstream and 
downstream factors  – such as consent rates, donor 
optimization, improved organ preservation, and more 
rigorous recipient selection – may positively impact upon 
organ donor rates and trans plantation outcomes, the 
relationship between any of these factors and donation 
and transplantation outcomes is not straightforward. Th e 
impact of end-of-life care and decision-making on rates 
of brain death and organ donation is even less clear.
Figure 1. Deceased donation rates for countries achieving >20 donors per million population per year 1989–2010. Graph demonstrating 
the general trend toward consistently increasing deceased organ donor rates over time in the countries with the world’s highest deceased organ 
donor rates. This illustrates that decreasing trauma rates have not adversely aff ected rates of organ donation in these countries. Data from [6,15].
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While there is some literature dealing with end-of-life 
practices in ICU settings [32-34], there is much less 
litera ture that makes explicit the tension between 
palliative care and organ donation and it remains unclear 
why there are such signiﬁ cant diﬀ erences in rates of brain 
death in developed countries when the factors that lead 
to brain death are likely to be broadly equivalent in these 
countries and other metrics that one may expect to be 
salient, such as the number of ICU beds per capita, 
appear to have little inﬂ uence on brain death rates or 
organ donation rates [35]. One possibility is that the high 
rates of brain death observed in all countries that have 
high deceased donor rates may be related to more 
aggressive interventional approaches to end-of-life care 
that are part of these countries’ standard treatment 
proto cols in intensive care [36-38]. Conversely, developed 
countries with lower rates of brain death  – such as 
Australia, where brain death is normally only formally 
diagnosed when the potential donor’s family has agreed 
to donation [39]  – may approach end-of-life care less 
aggressively, may stress treatment withdrawal and pallia-
tion for cases in which treatment is deemed to be futile, 
may be less likely to emphasize the value of intensive care 
admission and cardiorespiratory support, and may be less 
likely to seek a diagnosis of brain death.
Cultural and religious factors aff ecting death 
management
Diﬀ erent approaches to end-of-life care and diﬀ erent 
social conventions regarding what is and what is not 
appropriate or acceptable during life’s ﬁ nal moments are 
likely to reﬂ ect cultural values, religious beliefs, legal 
norms and medical practices. Collectively, these may 
determine the extent to which technology is integrated 
into death’s approach and arrival, the speciﬁ c point at 
which society considers a person to be well and truly 
dead, and the use of heroic measures, including intensive 
care. Th ese approaches to end-of-life care are critically 
important with regard to the success of organ donation 
and transplantation programs because they will 
determine when and how frequently brain death is used 
as the criterion by which death is declared. In cultural 
settings where aggressive intensive care is not the norm, 
patients are less likely to progress through to a diagnosis 
of brain death. Where faith traditions privilege bodily 
integrity, cosmological integration, rapid burial, or 
prolonged rituals of grieving (as may be the case with 
both eastern and Abrahamic faith traditions), there may 
be less support for the application of biotechnology at the 
end of life and for organ donation.
A number of factors may mitigate against the appli-
cation of intensive and invasive technology during end-
of-life care (and therefore the diagnosis of brain death), 
including: Do Not Resuscitate orders and advance care 
planning that limits the provision of invasive treatment; 
professional reluctance to provide futile care; policies 
that restrict admission of futile cases into intensive care; 
availability of ICU resources; increased social and political 
support for palliative care and services that enable death 
in community settings; sociocultural attitudes against the 
Figure 2. Deceased donation rates per million population by donation after brain death and cardiocirculatory death, 2010. Graphic 
demonstrating the strong predominance of contribution from donation after brain death (DBD) and minimal donation after cardiocirculatory death 
(DCD) to deceased organ donation rates of countries with the highest donation rates. pmp, per million population. Data from [6,15].
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application of invasive technologies at the end of life; and 
increasing public and professional emphasis on ensuring 
that people with terminal illness have a good death.
A diffi  cult choice: intimacy versus utility
To increase rates of organ donation in countries which 
privilege advance care planning and treatment with-
drawal over aggressive treatment in intensive care  – 
particularly in patients with severe brain injury – policy-
makers and health professionals confront a diﬃ  cult 
choice. Th e measures necessary to increase rates of brain 
death, and thereby the availability of transplantable 
organs, would require fundamental changes in clinical 
care at the end of life  – changes that may appear in-
consistent with accepted norms surrounding what consti-
tutes appropriate care at the end of life and the appro-
priate management of a good death.
One option available to countries with low deceased 
donation rates is to try to raise rates of brain death by 
redeﬁ ning what is considered appropriate treatment in 
end-of-life care  – speciﬁ cally, to normalize the wide-
spread application of technology at the end of life and to 
continue cardiorespiratory support in patients who 
currently have treatment withdrawn as part of the active 
management of their dying [40]. Th e impact of such a 
move (as has been recently proposed in the UK [41,42]) 
would be profound – increasing expenditure at the end of 
life, increasing ICU admission rates and the number of 
ICU beds required, privileging intensive care over 
palliative and chronic care, readjusting our expectation of 
advance care planning to accommodate interventions 
that maximize organ donation potential, adjustment of 
public health policies to encourage hospital-based and 
intensive care, and changing social attitudes and 
expectations regarding where and how we should die. 
Each of these strategies requires fundamental changes to 
our attitudes and expectations regarding the way in 
which we die. Each would also represent a major policy 
reversal from eﬀ orts in most common law countries, 
which in recent decades have generally rejected moves 
toward presumed consent legislation and have aimed to 
decrease levels of unwanted end-of-life interventions and 
to increase the eﬀ ectiveness of advance care planning for 
treatment limitation [43].
Th e other option is to accept lower brain death rates 
and constrained numbers of deceased organ donors as a 
consequence of maintaining approaches that limit end-
of-life interventions and futile care and that encourage 
advance care planning, treatment limitation and dying in 
community and hospice settings.
One of these options is concerned primarily with the 
best interest of the dying patient while the other sacriﬁ ces 
some degree of intimacy in dying for the social utility of 
organs and tissues. Moreover, it conjugates a previously 
singular sanctity of focus on a peaceful, minimally 
intrusive pathway to death for a more aggressive and 
mechanical approach that views a patient’s death not just 
as an unfortunate tragedy but also as a potential utility to 
helping others.
Clearly it is important to continue research into strate-
gies that may increase the recruitment of organ donors 
and raise rates of consent for donation, into methods for 
optimizing organ and patient outcomes following DCD, 
and into the emergent sciences that may ultimately 
Figure 3. Brain death rates and 2010 deceased donation rates. Brain death (BD) rates and 2010 deceased donation (DD) rates of countries 
with published national rates of BD. Graphic demonstrating a high degree of correlation between countries with high (>40 per million population 
(pmp)) rates of BD and high (>20 pmp) DD rates. The lower DD rates for the UK and Australia correlate with their lower BD rates. Data for DD from 
[6]. Data for BD from [16] for Spain, [20] for France, [44] for USA midpoint, [38] for Belgium, [45] for the UK, and [46] for Australia.
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reduce our reliance upon organ donation. At this point, 
however, the evidence is clear – only through increasing 
the diagnosis of brain death can countries realize the 
numbers of deceased organ donors needed to best meet 
the demand for organs for transplantation. We believe it 
is time to put aside the idea that we can signiﬁ cantly 
increase deceased organ donation rates without 
signiﬁ cantly increasing brain death rates. Doing so will 
enable the public and professional debate to move to 
where we believe it should be – a discussion about what 
we are prepared to do and what we are prepared to give 
up, in order to expand our transplantation programs.
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